tirzepatide going off market FDA confirms shortage is still over, gives compounders a grace period FDA Allows Compounded Tirzepatide During
Description
Stopping tirzepatide abruptly is not recommended without provider guidance

Both compounds are synthetic peptide agonists studied for their interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors

If you are following a structured meal plan , you need to eat enough protein and nutrients even when appetite is suppressed

However, severe or persistent nausea and vomiting require medical attention

Tirzepatide , sold under the brand name Mounjaro , is primarily prescribed to improve glycemic control, alongside diet and exercise, in adults with type 2 diabetes
